Regulation of CD133 by HDAC6 Promotes β-Catenin Signaling to Suppress Cancer Cell Differentiation
Open Access
- 18 October 2012
- journal article
- research article
- Published by Elsevier BV in Cell Reports
- Vol. 2 (4), 951-963
- https://doi.org/10.1016/j.celrep.2012.09.016
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- CD133 Protein N-Glycosylation Processing Contributes to Cell Surface Recognition of the Primitive Cell Marker AC133 EpitopeJournal of Biological Chemistry, 2011
- Selective inhibition of histone deacetylase 6 (HDAC6) induces DNA damage and sensitizes transformed cells to anticancer agentsProceedings of the National Academy of Sciences, 2010
- A Lentiviral Functional Proteomics Approach Identifies Chromatin Remodeling Complexes Important for the Induction of PluripotencyMolecular & Cellular Proteomics, 2010
- The Microtubule-associated Histone Deacetylase 6 (HDAC6) Regulates Epidermal Growth Factor Receptor (EGFR) Endocytic Trafficking and DegradationJournal of Biological Chemistry, 2010
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- Small molecule–mediated disruption of Wnt-dependent signaling in tissue regeneration and cancerNature Chemical Biology, 2009
- Requirement of HDAC6 for Transforming Growth Factor-β1-induced Epithelial-Mesenchymal TransitionJournal of Biological Chemistry, 2008
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem CellsCell, 2008
- Let-7 expression defines two differentiation stages of cancerProceedings of the National Academy of Sciences, 2007
- HDAC6 Modulates Cell Motility by Altering the Acetylation Level of CortactinMolecular Cell, 2007